Trial Profile

Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing Chemotherapy

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 27 May 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Mifomelatide (Primary)
Indications Cachexia
Focus Adverse reactions; Therapeutic Use
Acronyms Paradox
Sponsors Endevica Bio

Most Recent Events

11 May 2026 Planned End Date changed from 1 Sep 2026 to 1 Jun 2027.
11 May 2026 Planned primary completion date changed from 1 Jun 2026 to 1 Mar 2027.
17 Apr 2026 According to a Kalohexis media release, a trial-in-progress poster will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22, 2026 in San Diego, CA.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com